Cases Alleging Dupixent Causes Rare Cancer Centralized In N.J. Federal Court
WASHINGTON, D.C. — The U.S. Judicial Panel on Multidistrict Litigation (JPMDL) centralized cases alleging that Dupixent XE "Dupixent" , a prescription medication used for the treatment of asthma and inflammatory skin...To view the full article, register now.
Already a subscriber? Click here to view full article